Abstract:Preterm infants are at particularly high risk for infectious diseases. As this vulnerability extends beyond the neonatal period into childhood and adolescence, preterm infants benefit greatly from infection-preventive measures such as immunizations. However, there is an ongoing discussion about vaccine safety and efficacy due to preterm infants' distinct immunological features. A significant proportion of infants remains un- or under-immunized when discharged from primary hospital stay. Educating health care professionals and parents, promoting maternal immunization and evaluating the potential of new vaccination tools are important means to reduce the overall burden from infectious diseases in preterm infants. In this narrative review, we summarize the current knowledge about vaccinations in premature infants. We discuss the specificities of early life immunity and memory function, including the role of polyreactive B cells, restricted B cell receptor diversity and heterologous immunity mediated by a cross-reactive T cell repertoire. Recently, mechanistic studies indicated that tissue-resident memory (Trm) cell populations including T cells, B cells and macrophages are already established in the fetus. Their role in human early life immunity, however, is not yet understood. Tissue-resident memory T cells, for example, are diminished in airway tissues in neonates as compared to older children or adults. Hence, the ability to make specific recall responses after secondary infectious stimulus is hampered, a phenomenon that is transcriptionally regulated by enhanced expression of T-bet. Furthermore, the microbiome establishment is a dominant factor to shape resident immunity at mucosal surfaces, but it is often disturbed in the context of preterm birth. The proposed function of Trm T cells to remember benign interactions with the microbiome might therefore be reduced which would contribute to an increased risk for sustained inflammation. An improved understanding of Trm interactions may determine novel targets of vaccination, e.g., modulation of T-bet responses and facilitate more individualized approaches to protect preterm babies in the future.

Neonatal immunity and immunisation in early age: lessons from veterinary medicine

Immune system development in the dog and cat

Development of a Novel Canine Parvovirus Vaccine Capable of Stimulating Protective Immunity in Four-Week-Old Puppies in the Face of High Levels of Maternal Antibodies

Age and long-term protective immunity in dogs and cats

Neonatal and infant immunity for tuberculosis vaccine development: importance of age-matched animal models

Understanding Early-Life Adaptive Immunity to Guide Interventions for Pediatric Health

Natural and artificial hyperimmune solutions: Impact on health in puppies

Passive immune transfer in puppies

Advantages and Limitations of the Neonatal Immune System

Enteral immunization with live bacteria reprograms innate immune cells and protects neonatal foals from pneumonia

Topics on maternal, fetal and neonatal immunology of dogs and cats

Canine Amniotic Fluid at Birth Holds Information about Neonatal Antibody Titres against Core Vaccine Viruses

Maternal immunity protects offspring from enteric viral infection without negatively affecting humoral immune memory

Immunization of preterm infants: current evidence and future strategies to individualized approaches

Vaccine-induced time- and age-dependent mucosal immunity to gastrointestinal parasite infection

Effective priming of neonates born to immune dams against the immunogenic pseudorabies virus glycoprotein gD by replication-incompetent adenovirus-mediated gene transfer at birth.

Discrepancy Between In-clinic and Haemagglutination-Inhibition Tests in Detecting Maternally-Derived Antibodies Against Canine Parvovirus in Puppies

Relative immunocompetence of the newborn harbour seal, Phoca vitulina

Oral administration of modified live canine parvovirus type 2b induces systemic immune response

[Passive immunization in dogs and cats]

Effect of maternal antibodies on the immune response to different canine parvovirus vaccines and antibody response to selected vaccines